Great, more diagnostic tests, exactly what we need. The amount of effort and resources being poured into developing diagnostics for every manner of condition and disease continues to grow exponentially. Meanwhile resources devoted to new treatments or for (heaven forbid!) prevention have continued to shrink. As one who has lived in the assay development world for almost my entire career I totally understand the appeal of the diagnostics market from a commercial perspective. Diagnostics take much less R&D resources to develop, are cash cows (the razor/razor blade model is the typical format, sell for a loss or place for free an instrument, and then be the sole provider of reagents and/or other consumables and/or software needed to use), and are much lower risk from a liability perspective than a drug or other treatment option. And yes they can and do save lives, but we need to restore some balance and sanity in the clinical R&D world. If we don’t we are going to end up living in a world in which we can tell you exactly what is wrong with you in a hundred different ways, but only have one or no ways to fix you.